{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Temple",
      "address_1": "5920 S General Bruce Dr",
      "reason_for_recall": "Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.",
      "address_2": "Ste 100",
      "product_quantity": "325,225 units (syringes, vials, bags)",
      "code_info": "All Lots",
      "center_classification_date": "20141009",
      "distribution_pattern": "Nationwide",
      "state": "TX",
      "product_description": "All sterile products within expiry",
      "report_date": "20141015",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Unique Pharmaceutical, Ltd",
      "recall_number": "D-0012-2015",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "product_type": "Drugs",
      "event_id": "68841",
      "termination_date": "20160224",
      "more_code_info": "",
      "recall_initiation_date": "20140718",
      "postal_code": "76502-5803",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}